ArticleCell communication and signaling : CCS2026
The SDF-1α/CXCR4 axis regulates chondrocyte mitochondrial dynamics via the ERK/AMPKα pathway.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Mitochondrial quality control is crucial for maintaining chondrocyte homeostasis, and mitochondrial dysfunction is a key contributor to osteoarthritic (OA) pathogenesis. Reports have indicated that the level of SDF-1α increases during the progression of OA; however, its effects on mitochondrial dynamics in chondrocytes remain poorly understood. This study investigated the effects of SDF-1α on mitochondrial changes and its underlying molecular mechanisms. We found that SDF-1α reduced the number of mitochondria, caused the generation of many granular mitochondria via mitochondrial dynamics, and resulted in enhanced mitophagy in chondrocytes. SDF-1α activated AMPKα signalling and promoted its nuclear translocation to achieve these changes in mitochondria. Moreover, SDF-1α-induced mitochondrial changes require the participation of the receptor CXCR4, and the SDF-1α/CXCR4 regulatory axis increases cytoplasmic MAPK/ERK signalling to promote AMPKα-controlled mitochondrial changes. This study enhances our understanding of the role of SDF-1α in mitochondrial changes in chondrocytes and suggests the potential of therapeutic strategies for OA by targeting mitochondrial function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.